{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:56:37Z","timestamp":1786737397822,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Rural Med"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/cjrm.cjrm_67_20","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T10:10:02Z","timestamp":1609236602000},"page":"14","source":"Crossref","is-referenced-by-count":4,"title":["Fluoroquinolone use in a rural practice"],"prefix":"10.4103","volume":"26","author":[{"given":"Len","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YokoS","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Hopko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ribal","family":"Kattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharen","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1203-7796.305233-1","unstructured":"Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System-Update 2020. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-2020-report.html. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-2","first-page":"333","volume-title":"Development of an antimicrobial stewardship program in a rural and remote health authority","author":"Pammett","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"key-10.4103\/1203-7796.305233-3","first-page":"1","volume-title":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings","author":"Leis","year":"2020","journal-title":"Can Commun Dis Rep"},{"key":"key-10.4103\/1203-7796.305233-4","first-page":"134","volume-title":"Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits","author":"Kabbani","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1203-7796.305233-5","unstructured":"Crain J, McPherson J, Raj M, Singh K, Ford C. Fluoroquinolone Prescribing and use in Canadian Primary Care Practice. Ottawa: CADTH; 2017 CADTH; 2017 Mar. (CADTH Technology Review; No. 5). Available from: https:\/\/www.cadth.ca\/dv\/fluoroquinolone-prescribing-and-use-canadian-primary-care-practice. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-6","first-page":"863","volume-title":"Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada","author":"Carrie","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/1203-7796.305233-7","first-page":"207","volume-title":"The new fluoroquinolones: A critical review","author":"Zhanel","year":"1999","journal-title":"Can J Infect Dis"},{"key":"key-10.4103\/1203-7796.305233-8","first-page":"2019","volume-title":"A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000\u201306)","author":"Glass","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/1203-7796.305233-9","first-page":"E445","volume-title":"Regional variability in outpatient antibiotic use in Ontario, Canada: A retrospective cross-sectional study","author":"Schwartz","year":"2018","journal-title":"CMAJ Open"},{"key":"key-10.4103\/1203-7796.305233-10","first-page":"e010077","volume-title":"Fluoroquinolones and collagen associated severe adverse events: A longitudinal cohort study","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.4103\/1203-7796.305233-11","first-page":"1449","volume-title":"Aortic dissection and aortic aneurysms associated with fluoroquinolones: A systematic review and meta-analysis","author":"Singh","year":"2017","journal-title":"Am J Med"},{"key":"key-10.4103\/1203-7796.305233-12","unstructured":"Health Canada. Summary Safety Review-Fluoroquinolones-Assessing the Potential Risk of Persistent and Disabling Side Effects; 2017. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/safety-reviews\/summary-safety-review-fluoroquinolones-assessing-potential-risk-persistent-disabling-effects.html. [Last. [Last accessed on 2020 Mar 15]."},{"key":"key-10.4103\/1203-7796.305233-13","first-page":"1414","volume-title":"Oral fluoroquinolones and the risk of retinal detachment","author":"Etminan","year":"2012","journal-title":"JAMA"},{"key":"key-10.4103\/1203-7796.305233-14","first-page":"1261","volume-title":"Oral fluoroquinolone use and risk of peripheral neuropathy: A pharmacoepidemiologic study","author":"Etminan","year":"2014","journal-title":"Neurology"},{"key":"key-10.4103\/1203-7796.305233-15","first-page":"1839","volume-title":"Risk of aortic dissection in patients taking fluoroquinolones","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/1203-7796.305233-16","first-page":"3034","volume-title":"Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1\u03b2 inhuman tendon-derived cells","author":"Corps","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1203-7796.305233-17","first-page":"36:1401","volume-title":"Fluoroquinolone-associated tendinopathy: A critical review of the literature","author":"KhaliqY,","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1203-7796.305233-18","first-page":"8023935","volume-title":"Treatment of the fluoroquinolone-associated disability: The pathobiochemical implications","author":"Michalak","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"key-10.4103\/1203-7796.305233-19","unstructured":"US Food and Drug Administration. FDA Warns About Increased Risk of Ruptures or Tears in the Aorta Blood Vessel with Fluoroquinolone Antibiotics in Certain Patients; 2018. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-20","unstructured":"US Food and Drug Administration. FDA Updates Warnings for Fluoroquinolone Antibiotics on Risks of mental Health and Low Blood Sugar Adverse Reactions; 2018. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-health-and-low-blood-sugar-adverse. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-21","unstructured":"US Food and Drug Administration. FDA Updates Warnings for Fluoroquinolone Antibiotics; 2016. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-22","unstructured":"American Urological Association; 2017. Available from: http:\/\/www.choosingwisely.org\/clinician-lists\/american-urological-association-fluoroquinolones-for-uncomplicated-cystitis-in-women\/. [Last accessed on 2020 Mar 15]."},{"key":"key-10.4103\/1203-7796.305233-23","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD 2018 Index. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/. [Last accessed on 2018 Mar 22]."},{"key":"key-10.4103\/1203-7796.305233-24","first-page":"e20162706","volume-title":"The use of systemic and topical fluoroquinolones","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"key-10.4103\/1203-7796.305233-25","first-page":"e45","volume-title":"Diagnosis and treatment of adults with community-acquired pneumonia an official clinical practice guideline of the American thoracic society and infectious diseases society of America","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1203-7796.305233-26","unstructured":"Antimicrobial Resistance in Common Hospital Pathogens in Ontario. Public Health Ontario. Available from: http:\/\/www.publichealthontario.ca\/en\/eRepository\/ARO_Survey_Report_2015.pdf. [Last accessed on 2020 Aug 17]."},{"key":"key-10.4103\/1203-7796.305233-27","unstructured":"Sioux Lookout Meno Ya Win Health Centre. 2015 Laboratory Antibiogram. Sioux Lookout, Ontario."},{"key":"key-10.4103\/1203-7796.305233-28","first-page":"1192","volume-title":"Evaluation of FDA boxed warning on prescribing pattern of fluoroquinolones for uncomplicated urinary tract infections","author":"Cowart","year":"2019","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/1203-7796.305233-29","first-page":"701","volume-title":"Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning","author":"Bratsman","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/1203-7796.305233-30","unstructured":"Northern Health Physicians. Antimicrobial Stewardship. Available from: https:\/\/physicians.northernhealth.ca\/physician-resources\/clinical-resources\/antimicrobial-stewardship-program#about. [Last accessed on 2020 Aug 17]."}],"container-title":["Canadian Journal of Rural Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:53:51Z","timestamp":1786733631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/cjrm.cjrm_67_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["305233"],"URL":"https:\/\/doi.org\/10.4103\/cjrm.cjrm_67_20","relation":{},"ISSN":["1203-7796"],"issn-type":[{"value":"1203-7796","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}